Abstract
The development of chalcones as antimitotic agents has led to the design of other analogues able to interact with tubulin and inhibit its assembly into microtubules. This activity has also been associated with their anti-vascular activity. This review focuses on the development of chalcones and related analogues as antimitotic agents.
MeSH terms
-
Animals
-
Antimitotic Agents / chemical synthesis
-
Antimitotic Agents / chemistry
-
Antimitotic Agents / pharmacology*
-
Chalcones / chemical synthesis
-
Chalcones / chemistry*
-
Chalcones / pharmacology*
-
Drug Design
-
Humans
-
Microtubules / drug effects*
-
Microtubules / metabolism*
-
Structure-Activity Relationship
-
Tubulin / chemistry
-
Tubulin / metabolism*
Substances
-
Antimitotic Agents
-
Chalcones
-
Tubulin